Inflammation-Driven Field Cancerization in End-Stage Kidney Disease
In this issue, Takahashi, Tanaka, and colleagues provide a comprehensive genomic, transcriptomic, and spatial analysis of renal cell carcinomas (RCC) associated with end-stage renal disease. They demonstrate that the clonal expansion of a subset of proximal tubule cells, supported by an inflammatory microenvironment, gives rise to the cysts of acquired cystic kidney disease as well as to acquired cystic disease-associated RCC. See related article by Takahashi et al., p. 478.
Authors
- Rebecca Sager
- Katalin Susztak
- A. Ari Hakimi
Institutions
- Memorial Sloan Kettering Cancer Center (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Cancer Discovery
- Published
- 2026-03-02
- DOI
- https://doi.org/10.1158/2159-8290.cd-25-2276
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00